Elbit gets FDA approval for ultrasound system:
This article was originally published in Clinica
Executive Summary
Elbit Ultrasound has received US marketing approval for its general purpose colour ultrasound system, Synergy. The PC-based system supports digital archiving and communications networks. Elbit, which is based in Haifa, Israel, has completed its acquisition of Elscint's ultrasound business and renamed it Diasonics Israel. Elbit believes a 2D spectral Doppler technique developed by Diasonics could have applications in the diagnosis of placental disorders.
You may also be interested in...
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Lack Of Industry Involvement In EU HTA Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.